Protocol Ledger

NCT03683576 · Phase II · COMPLETED

GB001 in Adult Subjects With Moderate to Severe Asthma

Interventional Phase II clinical trial protocol NCT03683576 sponsored by GB001, Inc, a wholly owned subsidiary of Gossamer Bio in Respiratory and Pulmonary, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-10-22 Enrollment: 481 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03683576
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)481 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03683576
Protocol FieldVerified Registry Value
NCT IdentifierNCT03683576
Consolidated Lead SponsorGB001, Inc, a wholly owned subsidiary of Gossamer Bio
Therapeutic Condition CohortRespiratory and Pulmonary
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment481 participants (ACTUAL)
Registered Start Date2018-10-22
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT03683576
Hospital Research SiteLocationSite Profile
Yale Cancer Center and Smilow Cancer HospitalNew Haven, CTOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI